(PDF) Second-Line Therapy for Elderly Patients With

Second-Line Therapy for Elderly Patients With Non-Small Cell Lung Cancer Who Failed Previous Chemotherapy Is as Effective as for Younger Patients

Journal of Thoracic Oncology - United States

doi 10.1097/jto.0b013e3181cee2d4

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

March 1, 2010

Authors

Ruery-Perng Perng

Publisher

Elsevier BV

Related search

Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

English

Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients

Korean Journal of Internal Medicine

Internal Medicine

English

Anti-Pd-1 Therapy Plus Chemotherapy and/or Bevacizumab as Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer

Journal of Cancer

English

Ramucirumab Combined With Paclitaxel as the Second-Line Chemotherapy for Elderly Patients With Disseminated Gastric Cancer

Medical Council

English

P013 Anti-Pd-1 Combination Therapy as Second Line Treatment or Beyond in Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Treatment Paradigms for Patients With Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line

Current Oncology

English

Efficacy and Safety of Icotinib as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy

English

Treatment Results Including More Than Third-Line Chemotherapy for Patients With Advanced Non-Small Cell Lung Cancer

Oncology Letters

Cancer Research

English

PCN37 Cost-Minimization Analysis of Second-Line Chemotherapy for Non-Small-Cell Lung Cancer (NSCLC)

Value in Health

Occupational Health

English